Experimental Therapeutics for Dystonia

This publication has 95 references indexed in Scilit:

• Paroxysmal dyskinesias in mice
  Movement Disorders, 2008
• Animal models for drug discovery in dystonia
  Expert Opinion on Drug Discovery, 2007
• Blepharospasm and limb dystonia caused by Mohr‐Tranebjaerg syndrome with a novel splice‐site mutation in the deafness/dystonia peptide gene
  Movement Disorders, 2007
• Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells
  Proceedings of the National Academy of Sciences, 2007
• Nifedipine Suppresses Self-Injurious Behaviors in Animals
  Developmental Neuroscience, 2006
• Mutant torsinA, which causes early‐onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH‐SY5Y cells
  Movement Disorders, 2004
• Brainstem pathology in DYT1 primary torsion dystonia
  Annals of Neurology, 2004
• Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment inCebus apella monkeys
  Movement Disorders, 2000
• The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
  Nature Genetics, 1997
• Induction of chorea and dystonia in parkinsonian primates
  Movement Disorders, 1990